Venture Capital doyen Cambridge Innovation Capital, which invests in major DeepTech and life sciences companies, has made two ...

NRG Therapeutics, a neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has closed an ...

Cambridge-based AI for materials science company CuspAI has confirmed a $100 million+ Series A round – led by global ...

Cambridge’s two universities and three NHS trusts have joined forces to find new industry partners to help them invent, test ...

Cambridge based pharma company Bicycle Therapeutics has onboarded two experienced new directors as it inches closer to ...

Cambridge biopharma company Alchemab Therapeutics has raised an additional $32 million to help advance its portfolio and has ...

Lithuanian multiomics data analysis pioneer VUGENE reveals that its Chief Scientific Officer, Ingrida Olendraitė, is ...

The use of drone technology in farming has grown tremendously over the past decade, writes Quentin Golder, a Partner in ...

Cambridge innovators are being handed the opportunity to unlock fresh US trade opportunities via a delegation to North ...

Cambridge University researchers have developed a material that can sense tiny changes within the body, such as during an ...

Law firm Mills & Reeve has advised independent connection provider HVSS Group on its maiden acquisition of a Norwich ...

Cambridge superchip architect Arm reveals that Telechips, a global fabless semiconductor manufacturer specialising in ...